v3.25.3
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
Series B Convertible Preferred Stock [Member]
Series C Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2023 $ 75 $ 13,468,216 $ (10,323,843) $ 3,144,448
Balance at beginning (in shares) at Dec. 31, 2023 756,745      
Net loss (1,191,809) (1,191,809)
Share based compensation 208,639   208,639
Warrants exercised for Common Stock $ 6 (6)    
Warrants exercised for shares of Common Stock (in shares)     62,500      
Issuance of Common Stock $ 4 199,996   200,000
Issuance of Common Stock (in shares)     36,227      
Shares issued for services $ 3 199,997   200,000
Shares issued for services (in shares)     24,510      
Ending balance, value at Mar. 31, 2024 $ 88 14,076,842 (11,515,652) 2,561,278
Balance at ending (in shares) at Mar. 31, 2024 879,981      
Beginning balance, value at Dec. 31, 2023 $ 75 13,468,216 (10,323,843) 3,144,448
Balance at beginning (in shares) at Dec. 31, 2023 756,745      
Net loss           (3,574,592)
Ending balance, value at Sep. 30, 2024 $ 109 15,357,244 (13,898,436) 1,458,918
Balance at ending (in shares) at Sep. 30, 2024 1,091,205      
Beginning balance, value at Mar. 31, 2024 $ 88 14,076,842 (11,515,652) 2,561,278
Balance at beginning (in shares) at Mar. 31, 2024 879,981      
Net loss   (938,146) (938,146)
Share based compensation   80,666   80,666
Warrants exercised for Common Stock $ 7 (7)    
Warrants exercised for shares of Common Stock (in shares)     70,724      
Ending balance, value at Jun. 30, 2024 $ 95 14,157,501 (12,453,799) 1,703,798
Balance at ending (in shares) at Jun. 30, 2024 950,705      
Net loss (1,444,637) (1,444,637)
Issuance of Common Stock and warrants, net of issuance costs of $468,588 $ 5 820,327   820,332
Issuance of Common Stock and warrants, net of issuance costs of $468,588 (in shares)     49,875      
Share based compensation 379,425   379,425
Warrants exercised for Common Stock $ 9 (9)    
Warrants exercised for shares of Common Stock (in shares)     90,625      
Ending balance, value at Sep. 30, 2024 $ 109 15,357,244 (13,898,436) 1,458,918
Balance at ending (in shares) at Sep. 30, 2024 1,091,205      
Beginning balance, value at Dec. 31, 2024 $ 3 $ 30 $ 121 17,259,406 (15,340,107) 1,919,453
Balance at beginning (in shares) at Dec. 31, 2024 25,975 303,041 1,208,919      
Net loss (1,306,523) (1,306,523)
Series B preferred stock converted to Common Stock $ (3) $ 97 (94)    
Series B preferred stock converted to Common Stock (in shares) (25,975)   972,149      
Warrants exercised for Common Stock $ 6 (6)    
Series C preferred stock converted to Common Stock $ (30) $ 30    
Warrants exercised for shares of Common Stock (in shares)     64,702      
Series C preferred stock converted to Common Stock (in shares)   (303,041) 303,041      
Issuance of warrants to purchase Series B preferred stock 9,000   9,000
Issuance of preferred stock and warrants, net of issuance costs of $382,800 $ 5 $ 53 3,457,216   3,457,274
Issuance of preferred stock and warrants, net of issuance costs of $382,800 (in shares) 46,025 536,959        
Ending balance, value at Mar. 31, 2025 $ 5 $ 53 $ 254 20,725,522 (16,646,630) 4,079,204
Balance at ending (in shares) at Mar. 31, 2025 46,025 536,959 2,548,811      
Beginning balance, value at Dec. 31, 2024 $ 3 $ 30 $ 121 17,259,406 (15,340,107) 1,919,453
Balance at beginning (in shares) at Dec. 31, 2024 25,975 303,041 1,208,919      
Net loss           (3,888,087)
Ending balance, value at Sep. 30, 2025 $ 1 $ 462 20,715,326 (19,228,194) 1,487,595
Balance at ending (in shares) at Sep. 30, 2025 1,260 4,620,837      
Beginning balance, value at Mar. 31, 2025 $ 5 $ 53 $ 254 20,725,522 (16,646,630) 4,079,204
Balance at beginning (in shares) at Mar. 31, 2025 46,025 536,959 2,548,811      
Net loss (1,327,486) (1,327,486)
Series B preferred stock converted to Common Stock $ (4) $ 154 (149)    
Series B preferred stock converted to Common Stock (in shares) (44,765)   1,535,067      
Series C preferred stock converted to Common Stock $ (38) $ 38   (10,047)
Series C preferred stock converted to Common Stock (in shares)   (383,517) 383,517      
Issuance costs (10,047)    
Ending balance, value at Jun. 30, 2025 $ 1 $ 15 $ 446 20,715,326 (17,974,116) 2,741,672
Balance at ending (in shares) at Jun. 30, 2025 1,260 153,442 4,467,395      
Net loss (1,254,078) (1,254,078)
Series C preferred stock converted to Common Stock $ (15) $ 15    
Series C preferred stock converted to Common Stock (in shares)   (153,442) 153,442      
Ending balance, value at Sep. 30, 2025 $ 1 $ 462 $ 20,715,326 $ (19,228,194) $ 1,487,595
Balance at ending (in shares) at Sep. 30, 2025 1,260 4,620,837